Cellectar Biosciences Stock Forecast - Simple Regression
| CLRB Stock | USD 3.79 0.02 0.52% |
The Simple Regression forecasted value of Cellectar Biosciences on the next trading day is expected to be 3.41 with a mean absolute deviation of 0.34 and the sum of the absolute errors of 21.10. Cellectar Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cellectar Biosciences stock prices and determine the direction of Cellectar Biosciences's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cellectar Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Cellectar Biosciences' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (2.43) | EPS Estimate Current Year (8.92) | EPS Estimate Next Year (7.52) | Wall Street Target Price 47 | EPS Estimate Current Quarter (2.53) |
Using Cellectar Biosciences hype-based prediction, you can estimate the value of Cellectar Biosciences from the perspective of Cellectar Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cellectar Biosciences using Cellectar Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cellectar using crowd psychology based on the activity and movement of Cellectar Biosciences' stock price.
Cellectar Biosciences Implied Volatility | 0.0 |
Cellectar Biosciences' implied volatility exposes the market's sentiment of Cellectar Biosciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cellectar Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cellectar Biosciences stock will not fluctuate a lot when Cellectar Biosciences' options are near their expiration.
The Simple Regression forecasted value of Cellectar Biosciences on the next trading day is expected to be 3.41 with a mean absolute deviation of 0.34 and the sum of the absolute errors of 21.10. Cellectar Biosciences after-hype prediction price | USD 3.32 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cellectar | Build AI portfolio with Cellectar Stock |
Open Interest Against 2026-02-20 Cellectar Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cellectar Biosciences' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cellectar Biosciences' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cellectar Biosciences stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cellectar Biosciences' open interest, investors have to compare it to Cellectar Biosciences' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cellectar Biosciences is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cellectar. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Cellectar Biosciences Additional Predictive Modules
Most predictive techniques to examine Cellectar price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cellectar using various technical indicators. When you analyze Cellectar charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cellectar Biosciences Simple Regression Price Forecast For the 25th of January
Given 90 days horizon, the Simple Regression forecasted value of Cellectar Biosciences on the next trading day is expected to be 3.41 with a mean absolute deviation of 0.34, mean absolute percentage error of 0.16, and the sum of the absolute errors of 21.10.Please note that although there have been many attempts to predict Cellectar Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cellectar Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cellectar Biosciences Stock Forecast Pattern
| Backtest Cellectar Biosciences | Cellectar Biosciences Price Prediction | Buy or Sell Advice |
Cellectar Biosciences Forecasted Value
In the context of forecasting Cellectar Biosciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cellectar Biosciences' downside and upside margins for the forecasting period are 0.04 and 9.90, respectively. We have considered Cellectar Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Cellectar Biosciences stock data series using in forecasting. Note that when a statistical model is used to represent Cellectar Biosciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.1072 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3404 |
| MAPE | Mean absolute percentage error | 0.1065 |
| SAE | Sum of the absolute errors | 21.1027 |
Predictive Modules for Cellectar Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cellectar Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cellectar Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Cellectar Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cellectar Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cellectar Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cellectar Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Cellectar Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cellectar Biosciences' historical news coverage. Cellectar Biosciences' after-hype downside and upside margins for the prediction period are 0.17 and 9.81, respectively. We have considered Cellectar Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cellectar Biosciences is slightly risky at this time. Analysis and calculation of next after-hype price of Cellectar Biosciences is based on 3 months time horizon.
Cellectar Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cellectar Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cellectar Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cellectar Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.29 | 6.49 | 0.02 | 0.08 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.79 | 3.32 | 12.40 |
|
Cellectar Biosciences Hype Timeline
Cellectar Biosciences is currently traded for 3.79. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.08. Cellectar is projected to decline in value after the next headline, with the price expected to drop to 3.32. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -12.4%, whereas the daily expected return is currently at 0.29%. The volatility of related hype on Cellectar Biosciences is about 2458.33%, with the expected price after the next announcement by competition of 3.87. The book value of the company was currently reported as 2.34. The company recorded a loss per share of 8.07. Cellectar Biosciences last dividend was issued on the 17th of July 2018. The entity had 1:30 split on the 24th of June 2025. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Historical Fundamental Analysis of Cellectar Biosciences to cross-verify your projections.Cellectar Biosciences Related Hype Analysis
Having access to credible news sources related to Cellectar Biosciences' direct competition is more important than ever and may enhance your ability to predict Cellectar Biosciences' future price movements. Getting to know how Cellectar Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cellectar Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AEON | AEON Biopharma | 0.18 | 10 per month | 5.84 | 0.01 | 10.34 | (10.67) | 33.74 | |
| BOLT | Bolt Biotherapeutics | 0.10 | 8 per month | 3.76 | 0.05 | 8.13 | (7.17) | 18.19 | |
| CING | Cingulate | 0.04 | 8 per month | 4.51 | 0.09 | 7.46 | (6.75) | 20.19 | |
| SNSE | Sensei Biotherapeutics | 1.85 | 8 per month | 5.97 | 0.01 | 17.33 | (10.69) | 36.61 | |
| LYRA | Lyra Therapeutics | (0.06) | 9 per month | 0.00 | (0.19) | 7.51 | (9.00) | 66.89 | |
| IMNN | Imunon Inc | 0.02 | 4 per month | 0.00 | (0.11) | 6.74 | (7.11) | 20.17 | |
| MRKR | Marker Therapeutics | (0.05) | 9 per month | 4.44 | 0.19 | 12.79 | (7.04) | 26.24 | |
| EVGN | Evogene | 0.01 | 7 per month | 0.00 | (0.08) | 3.77 | (5.22) | 21.65 | |
| RNAZ | Transcode Therapeutics | 0.62 | 7 per month | 0.00 | (0.11) | 7.42 | (8.21) | 29.47 | |
| MBIO | Mustang Bio | (0.07) | 7 per month | 0.00 | (0.14) | 7.00 | (6.31) | 21.51 |
Other Forecasting Options for Cellectar Biosciences
For every potential investor in Cellectar, whether a beginner or expert, Cellectar Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cellectar Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cellectar. Basic forecasting techniques help filter out the noise by identifying Cellectar Biosciences' price trends.Cellectar Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cellectar Biosciences stock to make a market-neutral strategy. Peer analysis of Cellectar Biosciences could also be used in its relative valuation, which is a method of valuing Cellectar Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cellectar Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Cellectar Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cellectar Biosciences shares will generate the highest return on investment. By undertsting and applying Cellectar Biosciences stock market strength indicators, traders can identify Cellectar Biosciences entry and exit signals to maximize returns.
| Accumulation Distribution | 1372.65 | |||
| Daily Balance Of Power | (0.10) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 3.79 | |||
| Day Typical Price | 3.79 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) |
Cellectar Biosciences Risk Indicators
The analysis of Cellectar Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cellectar Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cellectar stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.6 | |||
| Semi Deviation | 5.97 | |||
| Standard Deviation | 6.48 | |||
| Variance | 42.04 | |||
| Downside Variance | 37.76 | |||
| Semi Variance | 35.58 | |||
| Expected Short fall | (5.07) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cellectar Biosciences
The number of cover stories for Cellectar Biosciences depends on current market conditions and Cellectar Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cellectar Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cellectar Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cellectar Biosciences Short Properties
Cellectar Biosciences' future price predictability will typically decrease when Cellectar Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cellectar Biosciences often depends not only on the future outlook of the potential Cellectar Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cellectar Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 M | |
| Cash And Short Term Investments | 23.3 M |
Check out Historical Fundamental Analysis of Cellectar Biosciences to cross-verify your projections. For information on how to trade Cellectar Stock refer to our How to Trade Cellectar Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellectar Biosciences. If investors know Cellectar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cellectar Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cellectar Biosciences is measured differently than its book value, which is the value of Cellectar that is recorded on the company's balance sheet. Investors also form their own opinion of Cellectar Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Cellectar Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cellectar Biosciences' market value can be influenced by many factors that don't directly affect Cellectar Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cellectar Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cellectar Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellectar Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.